Previous close | 32.00 |
Open | 32.20 |
Bid | 32.20 x 0 |
Ask | 32.40 x 0 |
Day's range | 32.20 - 32.20 |
52-week range | 22.00 - 43.80 |
Volume | |
Avg. volume | 10 |
Market cap | 770.929M |
Beta (5Y monthly) | 1.18 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
OrthoPediatrics Corp (KIDS) reports a 41% surge in Q1 revenue, raises full-year guidance, and discusses strategic acquisitions and product launches.
Q1 2024 OrthoPediatrics Corp Earnings Call
While the top- and bottom-line numbers for OrthoPediatrics (KIDS) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.